血中高水平的环素A在转基因小鼠模型中增加了对性结肠炎的敏感性
Iuliia P Baikova1, Leonid A Ilchuk1, Marina V Kubekina1
1Institute of Gene Biology, Russian Academy of Sciences, Vavilov St., 34/5, Moscow 119334, Russia.
International journal of molecular sciences
|December 30, 2025
概括
研究人员开发了一种新的小鼠模型来研究炎症. 这种模型,具有较高的环素A (CypA) 水平,显示增强的炎症反应,特别是在大肠炎模型中,突出显示CypA作为一种抗炎性标.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 炎症是许多疾病的关键因素,影响患者的生活质量和死亡率.
- 鼠标模型对于研究人类自身免疫性疾病至关重要,但免疫系统同质性挑战了研究.
- 环素A (CypA) 是一种促炎因素,涉及到各种信号通路.
研究的目的:
- 开发一种新的转基因小鼠模型来研究炎症.
- 为了研究高环素A (CypA) 在炎症反应中的作用.
- 建立性结肠炎研究和抗CypA疗法测试的新模式.
主要方法:
- 产生了一个转基因小鼠模型,在血管内皮中产生了人类PPIA基因的Cre-依赖表达.
- 在激活后,可诱导的循环素A (CypA) 进入血液中的系统分泌.
- 诱导性结肠炎使用3%的硫酸溶液在饮用水中7天.
主要成果:
- 新的小鼠模型在激活时显示血液中CypA水平升高.
- 在DSS诱导后,小鼠表现出明显更严重的炎症,类似于性结肠炎.
- 结肠密室的恶化被观察到,而十二指肠仍然相对正常.
结论:
- 血液CypA升高增强诱导的炎症,但不会独立地启动它.
- CypA可能在促炎的积极反循环中发挥作用.
- 开发的小鼠菌株是结肠炎研究和评估抗CypA疗法的有价值模型.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
844
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
844
Drugs for Treatment of Ulcerative Colitis in IBD
413
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
413


